Literature DB >> 17143487

Knock-down of P-glycoprotein reverses taxol resistance in ovarian cancer multicellular spheroids.

Hui Xing1, Shixuan Wang, Danhui Weng, Gang Chen, Xiaokui Yang, Jianfeng Zhou, Gang Xu, Yunpin Lu, Ding Ma.   

Abstract

We previously established that multicellular ovarian cancer spheroids develop intrinsic multidrug resistance with the appearance of quiescent cell areas. p27 protein is a determinant of such resistance. However, the precise molecular basis of such resistance remains unknown. We demonstrated herein that these multicellular ovarian cancer spheroids expressed high levels of p27 and P-gp protein. Compared with monolayer cells, there is a significant increase in the resistance of spheroids cells to anticancer reagent Taxol. Antisense oligodeoxynucleotide not only mediated down-regulation of p27, but also P-gp expression in multicellular spheroids. Selective small interfering RNAs (siRNA) of P-gp with MDR1-targeted short hairpin RNAs (shRNA) expression vector sensitized the cells to Taxol. These results suggest that both p27 and P-gp can modulate Taxol sensitivity respectively, while p27 requires P-gp for its full function. Increased P-gp protein expression through p27 mediation is one of the major mechanisms of Taxol resistance in ovarian cancer multicellular spheroids.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17143487

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  15 in total

1.  siRNA-mediated down-regulation of P-glycoprotein in a Xenograft tumor model in NOD-SCID mice.

Authors:  Meysam Abbasi; Hamidreza Montazeri Aliabadi; Elaine H Moase; Afsaneh Lavasanifar; Kamaljit Kaur; Raymond Lai; Charles Doillon; Hasan Uludağ
Journal:  Pharm Res       Date:  2011-06-03       Impact factor: 4.200

2.  Combination of AKT inhibition with autophagy blockade effectively reduces ascites-derived ovarian cancer cell viability.

Authors:  Rohann J M Correa; Yudith Ramos Valdes; Teresa M Peart; Elena N Fazio; Monique Bertrand; Jacob McGee; Michel Préfontaine; Akira Sugimoto; Gabriel E DiMattia; Trevor G Shepherd
Journal:  Carcinogenesis       Date:  2014-02-22       Impact factor: 4.944

3.  Co-expression of CD147/EMMPRIN with monocarboxylate transporters and multiple drug resistance proteins is associated with epithelial ovarian cancer progression.

Authors:  Hongmin Chen; Li Wang; Julia Beretov; Jingli Hao; Weiwei Xiao; Yong Li
Journal:  Clin Exp Metastasis       Date:  2010-07-24       Impact factor: 5.150

4.  Inhibition of breast cancer invasion by TIS21/BTG2/Pc3-Akt1-Sp1-Nox4 pathway targeting actin nucleators, mDia genes.

Authors:  J-A Choi; Y S Jung; J Y Kim; H M Kim; I K Lim
Journal:  Oncogene       Date:  2015-03-23       Impact factor: 9.867

5.  Inhibition of mdr1 by G-quadruplex oligonucleotides and reversal of paclitaxel resistance in human ovarian cancer cells.

Authors:  Biao Wang; Shuo Li; Xin Meng; Hong Shang; Yifu Guan
Journal:  Tumour Biol       Date:  2015-03-24

6.  Hypoxia induced paclitaxel resistance in human ovarian cancers via hypoxia-inducible factor 1alpha.

Authors:  Lei Huang; Qilin Ao; Qinghua Zhang; Xiaokui Yang; Hui Xing; Fang Li; Gang Chen; Jianfeng Zhou; Shixuan Wang; Gang Xu; Li Meng; Yunping Lu; Ding Ma
Journal:  J Cancer Res Clin Oncol       Date:  2009-09-16       Impact factor: 4.553

7.  Optimizing molecular-targeted therapies in ovarian cancer: the renewed surge of interest in ovarian cancer biomarkers and cell signaling pathways.

Authors:  Donavon Hiss
Journal:  J Oncol       Date:  2012-02-06       Impact factor: 4.375

8.  Coexpression of invasive markers (uPA, CD44) and multiple drug-resistance proteins (MDR1, MRP2) is correlated with epithelial ovarian cancer progression.

Authors:  H Chen; J Hao; L Wang; Y Li
Journal:  Br J Cancer       Date:  2009-07-14       Impact factor: 7.640

9.  Cell-cycle synchronization reverses Taxol resistance of human ovarian cancer cell lines.

Authors:  Xueqing Wang; Lingya Pan; Ning Mao; Lifang Sun; Xiangjuan Qin; Jie Yin
Journal:  Cancer Cell Int       Date:  2013-07-30       Impact factor: 5.722

10.  An mDia2/ROCK signaling axis regulates invasive egress from epithelial ovarian cancer spheroids.

Authors:  Krista M Pettee; Kaitlyn M Dvorak; Andrea L Nestor-Kalinoski; Kathryn M Eisenmann
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.